{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:24:50Z","timestamp":1749756290805},"reference-count":102,"publisher":"University of Tokushima Faculty of Medicine","issue":"3.4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2021]]},"DOI":"10.2152\/jmi.68.220","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T22:09:32Z","timestamp":1636582172000},"page":"220-227","source":"Crossref","is-referenced-by-count":4,"title":["Varying clinical presentations of nontuberculous mycobacterial disease\u2005:\u2005Similar to but different from tuberculosis"],"prefix":"10.2152","volume":"68","author":[{"given":"Tsutomu","family":"Shinohara","sequence":"first","affiliation":[{"name":"Department of Community Medicine for Respirology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan"},{"name":"Division of Internal Medicine, Japan Agricultural Cooperatives Kochi Hospital, Kochi, Japan"},{"name":"Department of Clinical Investigation, National Hospital Organization Kochi Hospital, Kochi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Morizumi","sequence":"additional","affiliation":[{"name":"Department of Community Medicine for Respirology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan"},{"name":"Division of Internal Medicine, Japan Agricultural Cooperatives Kochi Hospital, Kochi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"Sumitomo","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Japan Agricultural Cooperatives Kochi Hospital, Kochi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, Mitarai S\u2005:\u2005Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis 22\u2005:\u20051116-1117, 2016","DOI":"10.3201\/eid2206.151086"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Prevots DR, Marras TK\u2005:\u2005Epidemiology of human pulmonary infection with nontuberculous mycobacteria\u2005:\u2005a review. Clin Chest Med 36\u2005:\u200513-34, 2015","DOI":"10.1016\/j.ccm.2014.10.002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mori T\u2005:\u2005Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 15\u2005:\u2005143-155, 2009","DOI":"10.1007\/s10156-009-0686-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Shibata Y, Horita N, Yamamoto M, Tsukahara T, Nagakura H, Tashiro K, Watanabe H, Nagai K, Nakashima K, Ushio R, Ikeda M, Narita A, Kanai A, Sato T, Kaneko T\u2005:\u2005Diagnostic test accuracy of anti-glycopeptidolipid-core IgA antibodies for Mycobacterium avium complex pulmonary disease\u2005:\u2005systematic review and meta-analysis. Sci Rep 6\u2005:\u200529325, 2016, doi\u2005:\u200510.1038\u2009\/\u2009srep29325","DOI":"10.1038\/srep29325"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kitada S, Maekura R, Yoshimura K, Miki K, Miki M, Oshitani Y, Nishida K, Sawa N, Mori M, Kobayashi K\u2005:\u2005Levels of Antibody against Glycopeptidolipid Core as a Marker for Monitoring Treatment Response in Mycobacterium avium Complex Pulmonary Disease\u2005:\u2005a Prospective Cohort Study. J Clin Microbiol 55\u2005:\u2005884-892, 2017","DOI":"10.1128\/JCM.02010-16"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dheda K, Gumbo T, Gandhi NR, Murray M, Theron G, Udwadia Z, Migliori GB, Warren R\u2005:\u2005Global control of tuberculosis\u2005:\u2005from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med 2\u2005:\u2005321-338, 2014","DOI":"10.1016\/S2213-2600(14)70031-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Tuberculosis Research Committee (RYOKEN), Tokyo, Japan\u2005:\u2005Nationwide survey of anti-tuberculosis drug resistance in Japan. Int J Tuberc Lung Dis 19\u2005:\u2005157-162, 2015","DOI":"10.5588\/ijtld.13.0905"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nitta AT, Davidson PT, de Koning ML, Kilman RJ\u2005:\u2005Misdiagnosis of multidrug-resistant tuberculosis possibly due to laboratory-related errors. JAMA 276\u2005:\u20051980-1983, 1996","DOI":"10.1001\/jama.276.24.1980"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ohji R, Shinohara T, Ohji H, Hatakeyama N, Iwamura S, Ogushi F\u2005:\u2005Pulmonary tuberculosis misdiagnosed as extensively drug-resistant tuberculosis due to selection of a nontuberculous mycobacterial colony from a preculture dish used for a drug-susceptibility test. Respir Investig 58\u2005:\u2005216-219, 2020","DOI":"10.1016\/j.resinv.2019.11.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Clarridge JE 3rd, Shawar RM, Shinnick TM, Plikaytis BB\u2005:\u2005Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol 31\u2005:\u20052049-2056, 1993","DOI":"10.1128\/jcm.31.8.2049-2056.1993"},{"key":"11","unstructured":"11. Yoshida H, Onohara K, Tazawa T, Tsurinaga Y, Kurokawa M, Han Y, Tamura Y, Nagai T, Hashimoto S, Kawase I\u2005:\u2005Comparative study of the efficacy of the COBAS TaqMan and LAMP assay for the rapid diagnosis of tuberculosis. Kekkaku 88\u2005:\u2005727-733, 2013 (in Japanese)"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Saito H, Iwamoto T, Ohkusu K, Otsuka Y, Akiyama Y, Sato S, Taguchi O, Sueyasu Y, Kawabe Y, Fujimoto H, Ezaki T, Butler R\u2005:\u2005Mycobacterium shinjukuense sp. nov., a slowly growing, non-chromogenic species isolated from human clinical specimens. Int J Syst Evol Microbiol 61(Pt 8)\u2005:\u20051927-1932, 2011","DOI":"10.1099\/ijs.0.025478-0"},{"key":"13","unstructured":"13. Aono A, Kazumi Y, Maeda S, Azuma Y, Tsuchiya S, Iwamoto T, Nakanaga K, Hayakawa K, Saito H\u2005:\u2005Non-tuberculous mycobacterium strains that show positive test for identification kits of M. tuberculosis complex. Kekkaku 85\u2005:\u2005461-464, 2010 (in Japanese)"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Watanabe K, Shinkai M, Yamaguchi N, Shinoda M, Hara Y, Ishigatsubo Y, Kaneko T\u2005:\u2005Mycobacterium shinjukuense lung disease that was successfully treated with antituberculous drugs. Intern Med 52\u2005:\u20052653-2655, 2013","DOI":"10.2169\/internalmedicine.52.1116"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Takeda K, Ohshima N, Nagai H, Sato R, Ando T, Kusaka K, Kawashima M, Masuda K, Matsui H, Aono A, Chikamatsu K, Mitarai S, Ohta K\u2005:\u2005Six Cases of Pulmonary Mycobacterium shinjukuense infection at a single hospital. Intern Med 55\u2005:\u2005787-791, 2016","DOI":"10.2169\/internalmedicine.55.5460"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ishiguro T, Saitoh J, Horie R, Hayashi T, Ishizuka T, Tsuchiya S, Yasukawa K, Kido T, Nakaguchi Y, Nishibuchi M, Ueda K\u2005:\u2005Intercalation activating fluorescence DNA probe and its application to homogeneous quantification of a target sequence by isothermal sequence amplification in a closed vessel. Anal Biochem 314\u2005:\u200577-86, 2003","DOI":"10.1016\/S0003-2697(02)00618-8"},{"key":"17","unstructured":"17. Takeda H, Hirose H, Ogura A, Kato Y, Sugiyama Y, Harada H, Fukuno Y, Yamamura T, Miyajima E\u2005:\u2005Comparison of Tosoh TRCRapid M.TB assay by transcription-reverse transcription concerted reaction (TRC) with Roche COBAS AMPLICOR assay by PCR and with culture for detection of Mycobacterium tuberculosis complex. Rinsho Byori 56\u2005:\u2005277-282, 2008 (in Japanese)"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Oshima K, Yokouchi H, Minemura H, Saito J, Tanino Y, Munakata M. Pulmonary infection caused by Mycobacterium shinjukuense. Ann Am Thorac Soc 12\u2005:\u2005958-959, 2015","DOI":"10.1513\/AnnalsATS.201503-124LE"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hayashi M, Matsukura S, Funaki T, Inoue D, Kazumi Y, Mitarai S, Kokubu F, Shikama Y\u2005:\u2005Clarithromycin-resistant Mycobacterium Shinjukuense lung disease\u2005:\u2005case report and literature review. Showa Univ J Med Sci 28\u2005:\u2005373-377, 2016","DOI":"10.15369\/sujms.28.373"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Taoka T, Shinohara T, Hatakeyama N, Iwamura S, Murase Y, Mitarai S, Ogushi F\u2005:\u2005Mycobacterium Shinjukuense pulmonary disease progressed to pleuritis after iatrogenic pneumothorax\u2005:\u2005a case report. J Clin Tuberc Other Mycobact Dis 19\u2005:\u2005100160, 2020, doi\u2005:\u200510.1016\u2009\/\u2009j.jctube.2020.100160.eCollection","DOI":"10.1016\/j.jctube.2020.100160"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Moon SM, Kim SY, Chung MJ, Lee SH, Shin SJ, Koh WJ\u2005:\u2005Nontuberculous mycobacterial lung disease caused by Mycobacterium shinjukuense\u2005:\u2005the first reported case in Korea. Tuberc Respir Dis (Seoul) 78\u2005:\u2005416-418, 2015","DOI":"10.4046\/trd.2015.78.4.416"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Luo L, Cao W, Chen W, Zhang R, Jing L, Chen H, Yu F, Yue J\u2005:\u2005Evaluation of the VITEK MS knowledge base version 3.0 for the identification of clinically relevant Mycobacterium species. Emerg Microbes Infect 7\u2005:\u2005114, 2018, doi\u2005:\u200510.1038\u2009\/s41426-018-0120-3","DOI":"10.1038\/s41426-018-0120-3"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wallace RJ Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, York DS, Shepherd S, Griffith DE\u2005:\u2005Macrolide\u2009\/\u2009Azalide therapy for nodular\u2009\/\u2009bronchiectatic mycobacterium avium complex lung disease. Chest 146\u2005:\u2005276-282, 2014","DOI":"10.1378\/chest.13-2538"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Koh WJ, Jeong BH, Kim SY, Jeon K, Park KU, Jhun BW, Lee H, Park HY, Kim DH, Huh HJ, Ki CS, Lee NY, Kim HK, Choi YS, Kim J, Lee SH, Kim CK, Shin SJ, Daley CL, Kim H, Kwon OJ\u2005:\u2005Mycobacterial characteristics and treatment outcomes in Mycobacterium abscessus lung disease. Clin Infect Dis 64\u2005:\u2005309-316, 2017","DOI":"10.1093\/cid\/ciw724"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nash KA, Brown-Elliott BA, Wallace RJ Jr\u2005:\u2005A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus, but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 53\u2005:\u20051367-1376, 2009","DOI":"10.1128\/AAC.01275-08"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Choi GE, Shin SJ, Won CJ, Min KN, Oh T, Hahn MY, Lee K, Lee SH, Daley CL, Kim S, Jeong BH, Jeon K, Koh WJ\u2005:\u2005Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med 186\u2005:\u2005917-925, 2012","DOI":"10.1164\/rccm.201111-2005OC"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Bastian S, Veziris N, Roux AL, Brossier F, Gaillard JL, Jarlier V, Cambau E\u2005:\u2005Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm (41) and rrl sequencing. Antimicrob Agents Chemother 55\u2005:\u2005775-781, 2011","DOI":"10.1128\/AAC.00861-10"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Haramati LB, Jenny-Avital ER, Alterman DD\u2005:\u2005Effect of HIV status on chest radiographic and CT findings in patients with tuberculosis. Clin Radiol 52\u2005:\u200531-35, 1997","DOI":"10.1016\/S0009-9260(97)80302-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Laissy JP, Cadi M, Boudiaf ZE, Casalino E, Crestani B, Bouvet E, Aubier M, Schouman-Claeys E\u2005:\u2005Pulmonary tuberculosis\u2005:\u2005computed tomography and high-resolution computed tomography patterns in patients who are either HIV-negative or HIV-seropositive. J Thorac Imaging 13\u2005:\u200558-64, 1998","DOI":"10.1097\/00005382-199801000-00014"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kirk O, Gatell JM, Mocroft A, Pedersen C, Proenca R, Brettle RP, Barton SE, Sudre P, Phillips AN, Lundgren JD for the EuroSIDA study group\u2005:\u2005Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. Am J Respir Crit Care Med 162(3 Pt 1)\u2005:\u2005865-872, 2000","DOI":"10.1164\/ajrccm.162.3.9908018"},{"key":"31","unstructured":"31. The Center for Disease Control and Prevention. the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America\u2005:\u2005Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. (Downloaded from https:\/\/aidsinfo.nih gov\u2009\/\u2009guidelines on 11\u2009\/\u200901\u2009\/\u20092020)"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Fujita J\u2005:\u2005Various Clinical and Pathological Findings of Pulmonary Non-tuberculous Mycobacteriosis-from the Viewpoint of Granuloma Formation-. JJSOG 39\u2005:\u200511-17, 2019(in Japanese)","DOI":"10.7878\/jjsogd.39.1_2_11"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Waller EA, Roy A, Brumble L, Khoor A, Johnson MM, Garland JL\u2005:\u2005The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease\u2005:\u2005Chest 130\u2005:\u20051234-1241, 2006","DOI":"10.1378\/chest.130.4.1234"},{"key":"34","unstructured":"34. Yuki M, Tokuda H, Nagai H, Moda M, Emoto N, Kasai S, Ookouchi Y\u2005:\u2005Three cases of rheumatoid arthritis complicated with nontuberculous mycobacterial disease showing extensive consolidation in chest imaging. Open J Respir 4\u2005:\u2005e00096, 2020 (in Japanese)"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Khan FY\u2005:\u2005Review of literature on disseminated tuberculosis with emphasis on the focused diagnostic workup. J Family Community Med 26\u2005:\u200583-91, 2019","DOI":"10.4103\/jfcm.JFCM_106_18"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. O'Connell ML, Birkenkamp KE, Kleiner DE, Folio LR, Holland SM, Olivier KN\u2005:\u2005Lung manifestations in an autopsy-based series of pulmonary or disseminated nontuberculous mycobacterial disease. Chest 141\u2005:\u20051203-1209, 2012","DOI":"10.1378\/chest.11-0425"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Fahim A, Khan MN\u2005:\u2005An unusual cause of miliary radiographic pattern. BMJ Case Rep 2011, doi\u2005:\u200510.1136\u2009\/\u2009bcr.10.2011.5060","DOI":"10.1136\/bcr.10.2011.5060"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Zota V, Angelis SM, Fraire AE, McNamee C, Kielbasa S, Libraty DH\u2005:\u2005Lessons from Mycobacterium avium complex-associated pneumonitis\u2005:\u2005a case report. J Med Case Rep 2\u2005:\u2005152, 2008","DOI":"10.1186\/1752-1947-2-152"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Hanak V, Kalra S, Aksamit TR, Hartman TE, Tazelaar HD, Ryu JH\u2005:\u2005Hot tub lung\u2005:\u2005presenting features and clinical course of 21 patients. Respir Med 100\u2005:\u2005610-615, 2006","DOI":"10.1016\/j.rmed.2005.08.005"},{"key":"40","unstructured":"40. Israel-Biet D, Venet A, Sandron D, Ziza JM, Chretien J\u2005:\u2005Pulmonary complications of intravesical Bacille Calmette-Gu\u00e9rin immunotherapy. Am Rev Respir Dis 135\u2005:\u2005763-765, 1987"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Tobiume M, Shinohara T, Kuno T, Mukai S, Naruse K, Hatakeyama N, Ogushi F\u2005:\u2005BCG-induced pneumonitis with lymphocytic pleurisy in the absence of elevated KL-6. BMC Pulm Med 14\u2005:\u200535, 2014, doi\u2005:\u200510.1186\u2009\/\u20091471-2466-14-35.","DOI":"10.1186\/1471-2466-14-35"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Okano Y, Shinohara T, Imanishi S, Takahashi N, Naito N, Taoka T, Kadota N, Ogushi F\u2005:\u2005Miliary pulmonary nodules due to Mycobacterium xenopi in a steroid-induced immunocompromised patient successfully treated with chemotherapy\u2005:\u2005a case report. BMC Pulm Med 16\u2005:\u200592, 2016, doi\u2005:\u200510.1186\u2009\/\u2009s12890-016-0252-y.","DOI":"10.1186\/s12890-016-0252-y"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Ose N, Maeda H, Takeuchi Y, Susaki Y, Kobori Y, Taniguchi S, Maekura R\u2005:\u2005Solitary pulmonary nodules due to non-tuberculous mycobacteriosis among 28 resected cases. Int J Tuberc Lung Dis 20\u2005:\u20051125-1129, 2016","DOI":"10.5588\/ijtld.15.0819"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Morimoto K, Hasegawa N, Izumi K, Among H, Uchimura K, Yoshiyama T, Hoshino Y, Kurashima A, Sokunaga J, Shibuya S, Shimojima M, Ato M, Mitarai S\u2005:\u2005A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013. Ann Am Thorac Soc 14\u2005:\u200549-56, 2017","DOI":"10.1513\/AnnalsATS.201607-573OC"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Kadota N, Shinohara T, Naruse K, Hino H, Ogushi F\u2005:\u2005A lobulated mass in the left lower lobe\u2005:\u2005not what it seems. Thorax 74\u2005:\u2005519-520, 2019","DOI":"10.1136\/thoraxjnl-2018-212520"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Rodriguez-Takeuchi SY, Renjifo ME, Medina FJ\u2005:\u2005Extrapulmonary tuberculosis\u2005:\u2005pathophysiology and imaging findings. Radiographics 39\u2005:\u20052023-2037, 2019","DOI":"10.1148\/rg.2019190109"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Barnes PF, Mistry SD, Cooper CL, Pirmez C, Rea TH, Modlin RL\u2005:\u2005Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 142\u2005:\u20051114-1119, 1989","DOI":"10.4049\/jimmunol.142.4.1114"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Momi H, Matsuyama W, Inoue K, Kawabata M, Arimura K, Fukunaga H, Osame M\u2005:\u2005Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respir Med 96\u2005:\u2005817-822, 2002","DOI":"10.1053\/rmed.2002.1364"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Shaw JA, Diacon AH, Koegelenberg CFN\u2005:\u2005Tuberculous pleural effusion. Respirology 24\u2005:\u2005962-971, 2019","DOI":"10.1111\/resp.13673"},{"key":"50","unstructured":"50. Patiala J\u2005:\u2005Initial tuberculous pleuritis in the Finnish armed forces in 1939-1945 with special reference to eventual postpleuritic tuberculosis. Acta Tuberc Scand 36 (Suppl)\u2005:\u20051-57, 1954"},{"key":"51","unstructured":"51. Roper WH, Waring JJ\u2005:\u2005Primary serofibrinous pleural effusion in military personnel. Am Rev Tuberc 71\u2005:\u2005616-634, 1955"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Shinohara T, Shiota N, Kume M, Hamada N, Naruse K, Ogushi F\u2005:\u2005Asymptomatic primary tuberculous pleurisy with intense 18-fluorodeoxyglucose uptake mimicking malignant mesothelioma. BMC Infect Dis 13\u2005:\u200512, 2013, doi\u2005:\u200510.1186\u2009\/\u20091471-2334-13-12.","DOI":"10.1186\/1471-2334-13-12"},{"key":"53","unstructured":"53. Kamiya H, Toyota E, Kobayashi N, Kudo K\u2005:\u2005A case of pulmonary Mycobacterium kansasii infection complicated with pleural effusion. Kekkaku 79\u2005:\u2005397-400, 2004 (in Japanese)."},{"key":"54","unstructured":"54. Ichiki H, Ueda S, Watanabe A, Sato C, Abe M\u2005:\u2005Nontuberculous pulmonary mycobacteriosis comlicated by pluritis. Nihon Kokyuki Gakkai Zasshi 49\u2005:\u2005885-889, 2011 (in Japanese)"},{"key":"55","unstructured":"55. Sado T, Nakamura Y, Kita H\u2005:\u2005Clinical analysis of nontuberculous mycobacterial infection complicated by pleurisy. Kekkaku 89\u2005:\u2005821-824, 2014 (in Japanese)"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Ando T, Kawashima M, Matsui H, Takeda K, Sato R, Ohshima N, Nagai H, Kitani M, Hebisawa A, Ohta K\u2005:\u2005Clinical Features and Prognosis of Nontuberculous Mycobacterial Pleuritis. Respiration 96\u2005:\u2005507-513, 2018","DOI":"10.1159\/000490548"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Nicholson TT, Mutlu GM\u2005:\u2005Pneumothorax following bronchoalveolar lavage for the diagnosis of non-tuberculous mycobacterial infection - An \u201catypical\u201d complication of bronchoscopy? Arch Bronconeumol 52\u2005:\u2005278-279, 2016","DOI":"10.1016\/j.arbr.2015.09.020"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Furuuchi K, Morimoto K, Fujiwara K, Tanaka Y, Takemura T, Kurashima A, Yoshimori K, Ohta K, Sasaki Y\u2005:\u2005Mycobacterium avium Complex Pleuritis with Elevated Anti-glycopeptidolipid-core IgA Antibody Levels in Pleural Effusion. Intern Med 58\u2005:\u20052577-2579, 2019","DOI":"10.2169\/internalmedicine.2751-19"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Maeda Y, Izawa K, Nabeshima T, Yonenobu K\u2005:\u2005Tuberculous spondylitis in elderly Japanese patients. J Orthop Sci 13\u2005:\u200516-20, 2008","DOI":"10.1007\/s00776-007-1197-z"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Kim CJ, Kim UJ, Kim HB, Park SW, Oh MD, Park KH, Kim NJ\u2005:\u2005Vertebral osteomyelitis caused by non-tuberculous mycobacteria\u2005:\u2005Predisposing conditions and clinical characteristics of six cases and a review of 63 cases in the literature. Infect Dis (Lond) 48\u2005:\u2005509-516, 2016","DOI":"10.3109\/23744235.2016.1158418"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Sarria JC, Chutkan NB, Figueroa JE, Hull A\u2005:\u2005Atypical mycobacterial vertebral osteomyelitis\u2005:\u2005case report and review. Clin Infect Dis 26\u2005:\u2005503-505, 1998","DOI":"10.1086\/517096"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Chan ED, Kong PM, Fennelly K, Dwyer AP, Iseman MD\u2005:\u2005Vertebral osteomyelitis due to infection with nontuberculous mycobacterium species after blunt trauma to the back\u2005:\u20053 examples of the principle of locus minoris resistentiae. Clin Infect Dis 32\u2005:\u20051506-1510, 2001","DOI":"10.1086\/320155"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Garcia DC, Sandoval-Sus J, Razzaq K, Young L\u2005:\u2005Vertebral osteomyelitis caused by Mycobacterium abscessus. BMJ Case Rep 2013, doi\u2005:\u200510.1136\u2009\/\u2009bcr-2013-009597","DOI":"10.1136\/bcr-2013-009597"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Edwards C, Diveronica M, Abel E\u2005:\u2005Epidural abscess caused by Mycobacterium abscessus. Am J Case Rep 13\u2005:\u2005180-182, 2012","DOI":"10.12659\/AJCR.883324"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Kadota N, Shinohara T, Hino H, Goda Y, Murase Y, Mitarai S, Ogushi F\u2005:\u2005Mycobacterium abscessus ssp. abscessus infection progressing to empyema from vertebral osteomyelitis in an immunocompetent patient without pulmonary disease\u2005:\u2005a case report. BMC Pulm Med 19\u2005:\u2005100, 2019, doi\u2005:\u200510.1186\u2009\/\u2009s12890-019-0860-4","DOI":"10.1186\/s12890-019-0860-4"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Inoue S, Moriyama T, Horinouchi Y, Tachibana T, Okada F, Maruo K, Yoshiya S\u2005:\u2005Comparison of clinical features and outcomes of staphylococcus aureus vertebral osteomyelitis caused by methicillin-resistant and methicillin-sensitive strains. Springerplus 2\u2005:\u2005283, 2013, doi\u2005:\u200510.1186\u2009\/\u20092193-1801-2-283","DOI":"10.1186\/2193-1801-2-283"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Bass SN, Ailani RK, Shekar R, Gerblich AA\u2005:\u2005Pyogenic vertebral osteomyelitis presenting as exudative pleural effusion\u2005:\u2005a series of five cases. Chest 114\u2005:\u2005642-647, 1998","DOI":"10.1378\/chest.114.2.642"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Matsushima T\u2005:\u2005Miliary tuberculosis or disseminated tuberculosis. Intern Med 44\u2005:\u2005687, 2005","DOI":"10.2169\/internalmedicine.44.687"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Henkle E, Winthrop KL\u2005:\u2005Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med 36\u2005:\u200591-99, 2015","DOI":"10.1016\/j.ccm.2014.11.002"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Wu UI, Holland SM\u2005:\u2005Host susceptibility to non-tuberculous mycobacterial infections. Lancet Infect Dis 15\u2005:\u2005968-980, 2015","DOI":"10.1016\/S1473-3099(15)00089-4"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, Kirk JL, Jutivorakool K, Zaman R, Ding L, Hsu AP, Patel SY, Olivier KN, Lulitanond V, Mootsikapun P, Anunnatsiri S, Angkasekwinai N, Sathapatayavongs B, Hsueh PR, Shieh CC, Brown MR, Thongnoppakhun W, Claypool R, Sampaio EP, Thepthai C, Waywa D, Dacombe C, Reizes Y, Zelazny AM, Saleeb P, Rosen LB, Mo A, Iadarola M, Holland SM\u2005:\u2005Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med 367\u2005:\u2005725-734, 2012","DOI":"10.1056\/NEJMoa1111160"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Aoki A, Sakagami T, Yoshizawa K, Shima K, Toyama M, Tanabe Y, Moro H, Aoki N, Watanabe S, Koya T, Hasegawa T, Morimoto K, Kurashima A, Hoshino Y, Trapnell BC, Kikuchi T\u2005:\u2005Clinical Significance of Interferon-\u03b3 Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease. Clin Infect Dis 66\u2005:\u20051239-1245, 2018","DOI":"10.1093\/cid\/cix996"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Horsburgh CR Jr\u2005:\u2005The pathophysiology of disseminated Mycobacterium avium complex disease in AIDS. J Infect Dis 179 (Suppl 3)\u2005:\u2005S461-465, 1999","DOI":"10.1086\/314804"},{"key":"74","unstructured":"74. Yagupsky P, Menegus MA\u2005:\u2005Cumulative positivity rates of multiple blood cultures for Mycobacterium avium-intracellulare and Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 114\u2005:\u2005923-925, 1990"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Vetter E, Torgerson C, Feuker A, Hughes J, Harmsen S, Schleck C, Horstmeier C, Roberts G, Cockerill F 3rd\u2005:\u2005Comparison of the BACTEC MYCO\u2009\/\u2009F Lytic bottle to the isolator tube, BACTEC Plus Aerobic F\u2009\/\u2009bottle, and BACTEC Anaerobic Lytic\u2009\/\u200910 bottle and comparison of the BACTEC Plus Aerobic F\u2009\/\u2009bottle to the Isolator tube for recovery of bacteria, mycobacteria, and fungi from blood. J Clin Microbiol 39\u2005:\u20054380-4386, 2001","DOI":"10.1128\/JCM.39.12.4380-4386.2001"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Tagashira Y, Kozai Y, Yamasa H, Sakurada M, Kashiyama T, Honda H\u2005:\u2005A cluster of central line-associated bloodstream infections due to rapidly growing nontuberculous mycobacteria in patients with hematologic disorders at a Japanese tertiary care center\u2005:\u2005an outbreak investigation and review of the literature. Infect Control Hosp Epidemiol 36\u2005:\u200576-80, 2015","DOI":"10.1017\/ice.2014.14"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Haddow LJ, Easterbrook PJ, Mosam A, Khanyile NG, Parboosing R, Moodley P, Moosa MY\u2005:\u2005Defining immune reconstitution inflammatory syndrome\u2005:\u2005evaluation of expert opinion versus 2 case definitions in a South African cohort. Clin Infect Dis 49\u2005:\u20051424-1432, 2009","DOI":"10.1086\/630208"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Narita M, Ashkin D, Hollender ES, Pitchenik AE\u2005:\u2005Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med 158\u2005:\u2005157-161, 1998","DOI":"10.1164\/ajrccm.158.1.9712001"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Lawn SD, Bekker LG, Miller RF\u2005:\u2005Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5\u2005:\u2005361-373, 2005","DOI":"10.1016\/S1473-3099(05)70140-7"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO\u2005:\u2005Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 38\u2005:\u20051261-1265, 2004","DOI":"10.1086\/383317"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Winthrop KL\u2005:\u2005Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor. Nat Clin Pract Rheumatol 2\u2005:\u2005602-10, 2006","DOI":"10.1038\/ncprheum0336"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Rivoisy C, Tubach F, Roy C, Nicolas N, Mariette X, Salmon D, Lortholary O, Bourgarit A\u2005;\u2005RATIO Group\u2005:\u2005Paradoxical anti-TNF-associated TB worsening\u2005:\u2005frequency and factors associated with IRIS. Joint Bone Spine 83\u2005:\u2005173-178, 2016","DOI":"10.1016\/j.jbspin.2015.04.022"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Matsumoto T, Tanaka T\u2005:\u2005Continuation of anti-TNF therapy for rheumatoid arthritis in patients with active tuberculosis reactivated during anti-TNF medication is more beneficial than its cessation. Infectious Diseases and Therapeutics 3\u2005:\u200535-37, 2015","DOI":"10.14205\/2310-9386.2015.03.01.6"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA\u2005:\u2005Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 15\u2005:\u20051556-1561, 2009","DOI":"10.3201\/eid1510.090310"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Takazono T, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yanagihara K, Kohno S\u2005:\u2005Paradoxical response to disseminated non-tuberculosis mycobacteriosis treatment in a patient receiving tumor necrosis factor-\u03b1 inhibitor\u2005:\u2005a case report. BMC Infect Dis 14\u2005:\u2005114, 2014, doi\u2005:\u200510.1186\u2009\/\u20091471-2334-14-114.","DOI":"10.1186\/1471-2334-14-114"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Lemoine M, Laurent C, Hanoy M, Leporrier J, Fran\u00e7ois A, Guerrot D, Godin M\u2005:\u2005Immune Reconstitution Inflammatory Syndrome Secondary to Mycobacterium kansasii infection in a kidney transplant recipient. Am J Transplant 15\u2005:\u20053255-3258, 2015","DOI":"10.1111\/ajt.13433"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Daum S, Moos V, Loddenkemper C, Sch\u00fcrmann C, M\u00e4rker-Hermann E, Stein H, Zeitz M, Schneider T\u2005:\u2005Immune reconstitution inflammatory syndrome (IRIS) of the small bowel in an immunocompromised patient suffering from systemic lupus erythematosus and non-tuberculous mycobacteriosis. Z Rheumatol 67\u2005:\u2005277-278, 2008 (in German)","DOI":"10.1007\/s00393-008-0298-1"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Langan EA, Graetz V, Allerheiligen J, Zillikens D, Rupp J, Terheyden P\u2005:\u2005Immune checkpoint inhibitors and tuberculosis\u2005:\u2005an old disease in a new context. Lancet Oncol 21\u2005:\u2005e55-e65, 2020","DOI":"10.1016\/S1470-2045(19)30674-6"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Cadranel J, Canellas A, Matton L, Darrason M, Parrot A, Naccache JM, Lavol\u00e9 A, Ruppert AM, Fallet V\u2005:\u2005Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer. Eur Respir Rev 28\u2005:\u2005190058, 2019, doi\u2005:\u200510.1183\u2009\/\u200916000617.0058-2019","DOI":"10.1183\/16000617.0058-2019"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Takata S, Koh G, Han Y, Yoshida H, Shiroyama T, Takada H, Masuhiro K, Nasu S, Morita S, Tanaka A, Hashimoto S, Uriu K, Suzuki H, Tamura Y, Okamoto N, Nagai T, Hirashima T\u2005:\u2005Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents. J Infect Chemother 25\u2005:\u200554-58, 2019","DOI":"10.1016\/j.jiac.2018.06.016"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Fujita K, Yamamoto Y, Kanai O, Okamura M, Nakatani K, Mio T\u2005:\u2005Development of Mycobacterium avium Complex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors. Open Forum Infect Dis 7\u2005:\u2005ofaa067, 2020 doi\u2005:\u200510.1093\u2009\/\u2009ofid\u2009\/\u2009ofaa067","DOI":"10.1093\/ofid\/ofaa067"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Ishii S, Tamiya A, Taniguchi Y, Tanaka T, Abe Y, Isa SI, Tsuyuguchi K, Suzuki K, Atagi S\u2005:\u2005Improvement of Mycobacterium abscessus pulmonary disease after nivolumab administration in a patient with advanced non-small cell lung cancer. Intern Med 57\u2005:\u20053625-3629, 2018","DOI":"10.2169\/internalmedicine.1195-18"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY\u2005:\u2005Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 21\u2005:\u2005803-809, 2002","DOI":"10.1007\/s10096-002-0821-2"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Breen RA, Smith CJ, Bettinson H, Dart S, Bannister B, Johnson MA, Lipman MC\u2005:\u2005Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection. Thorax 59\u2005:\u2005704-707, 2004","DOI":"10.1136\/thx.2003.019224"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Yano S, Kobayashi K, Kato K, Tokuda Y, Ikeda T, Takeyama H\u2005:\u2005Paradoxical worsening of pulmonary Mycobacterium abscessus. Respir Med 101\u2005:\u2005868-870, 2007","DOI":"10.1016\/j.rmed.2006.06.026"},{"key":"96","unstructured":"96. Shirayama R, Hamada K, Hayashi H, Tomoda K, Nakaya M, Yoshikawa M, Yoneda T, Narita N\u2005:\u2005Atypical mycobacteriosis (Mycobacterium xenopi) with "initial aggravation". Nihon Kyobu Shikkan Gakkai Zasshi 34\u2005:\u20051035-9, 1996 (in Japanese)"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Singh N, Perfect JR\u2005:\u2005Immune reconstitution syndrome and exacerbation of infections after pregnancy. Clin Infect Dis 45\u2005:\u20051192-1199, 2007","DOI":"10.1086\/522182"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Zenner D, Kruijshaar ME, Andrews N, Abubakar I\u2005:\u2005Risk of tuberculosis in pregnancy\u2005:\u2005a national, primary care-based cohort and self-controlled case series study. Am J Respir Crit Care Med 185\u2005:\u2005779-784, 2012","DOI":"10.1164\/rccm.201106-1083OC"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Cheng VC, Woo PC, Lau SK, Cheung CH, Yung RW, Yam LY, Yuen KY\u2005:\u2005Peripartum tuberculosis as a form of immunorestitution disease. Eur J Clin Microbiol Infect Dis 22\u2005:\u2005313-317, 2003","DOI":"10.1007\/s10096-003-0927-1"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Shinohara T, Kagawa K, Okano Y, Sawada T, Kobayashi T, Takikawa M, Iwahara Y, Ogushi F\u2005:\u2005Disseminated tuberculosis after pregnancy progressed to paradoxical response to the treatment\u2005:\u2005report of two cases. BMC Infect Dis 16\u2005:\u2005284, 2016, doi\u2005:\u200510.1186\u2009\/\u2009s12879-016-1624-x.","DOI":"10.1186\/s12879-016-1624-x"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Tsao SM, Liu KS, Liao HH, Huang TL, Shen GH, Tsao TC, Lee YT\u2005:\u2005The clinical management of cesarean section-acquired Mycobacterium abscessus surgical site infections. J Infect Dev Ctries 8\u2005:\u2005184-192, 2014","DOI":"10.3855\/jidc.3821"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Wu TS, Yang CH, Brown-Elliott BA, Chao AS, Leu HS, Wu TL, Lin CS, Griffith DE, Chiu CH\u2005:\u2005Postcesarean section wound infection caused by Mycobacterium massiliense. J Microbiol Immunol Infect 49\u2005:\u2005955-961, 2016","DOI":"10.1016\/j.jmii.2015.06.010"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/68\/3.4\/68_220\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T05:27:55Z","timestamp":1715146075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/68\/3.4\/68_220\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":102,"journal-issue":{"issue":"3.4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.68.220","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]}}}